CIK 0001107421
- Non-accelerated filer
- Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841475642
- Phone
- +1 346-355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 4 Grant or award EVP, CLO, and Secretary acquired 21,578 shares (grant or award)
- 4 Shares withheld for taxes President, COO & Treasurer gave up 7,908 shares (to pay taxes)
- 4 Grant or award Director acquired 17,577 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 38,294 shares at $4.99 ($191,087)
- 4 Open-market buy Director bought 461,646 shares at an average $4.92 ($2,272,821)
- 4 Open-market buy Director bought 5,000 shares at $5.19 ($25,926)
- 4 Open-market buy Director bought 846,522 shares at an average $4.78 ($4,042,234)
- 4 Grant or award Executive VP, CMO acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 15,000 shares at $6.53 ($97,950)
- 4 Open-market sale Director sold 15,000 shares at $6.57 ($98,615)
- 4 Open-market buy Director bought 1,910,000 shares at $5.75 ($10,982,500)
- 4 Open-market buy Director bought 6,063,161 shares at $4.80 ($11,645,928)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 15,190 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 24 · 465 filings